Thus, in both mouse embryonic fibroblasts and human breast cancer cells, RA treatment activates the p38 MAPK pathway to enhance transcription of Cyp26A1, one of the RA target genes [37]. The gene discussed is CYP26A1; the disease is breast cancer.